HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hakimi, J. Articles by Familletti, P. C. Search for Related Content PubMed PubMed Citation Articles by Hakimi, J. Articles by Familletti, P. C. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 262, Issue 36, 17336-17341, 12, 1987

Biochemical and functional analysis of soluble human interleukin-2 receptor produced in rodent cells. Solid-phase reconstitution of a receptor-ligand binding reaction

J Hakimi, C Seals, LE Anderson, FJ Podlaski, P Lin, W Danho, JC Jenson, A Perkins, PE Donadio and PC Familletti
Roche Research Center, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.

The binding of interleukin-2 (IL-2) to the IL-2 receptor (IL-2R) on human T-cells is a key regulatory event which is absolutely required for T-cell-mediated immune responses. To understand further this binding event, we modified the human IL-2R gene to encode a secreted form of IL-2R. Secreted IL-2R was then expressed at very high levels (approximately 11 micrograms/10(6) cells/48 h) in rodent cells using gene-linked co-amplification. The soluble forms of IL-2R were shown to retain IL-2 affinity shown by cell-surface IL-2R (Kd approximately 18 nM) and were purified to homogeneity using IL-2 affinity chromatography. Purified, recombinant IL-2R and biotinylated IL-2 were used to establish a solid-phase receptor binding assay. Binding of IL-2- biotin was demonstrated to be dose-dependent at concentrations ranging from 10 to 1000 ng/ml, and the specificity of receptor-ligand binding was demonstrated by competition with non-biotinylated IL-2 and with anti-receptor antibodies known to block IL-2 binding in vivo. This immunosorbent receptor assay offers a simple and rapid method for studying the binding of IL-2 to human IL-2R.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. B. Nussenblatt, E. Fortin, R. Schiffman, L. Rizzo, J. Smith, P. Van Veldhuisen, P. Sran, A. Yaffe, C. K. Goldman, T. A. Waldmann, et al. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial PNAS, June 22, 1999; 96(13): 7462 - 7466. [Abstract] [Full Text] [PDF]

				R. P. Junghans, A. L. Stone, and M. S. Lewis Biophysical Characterization of a Recombinant Soluble Interleukin 2 Receptor (Tac) J. Biol. Chem., May 3, 1996; 271(18): 10453 - 10460. [Abstract] [Full Text] [PDF]